Great news for seniors' access to innovative medical products. The proposed CMSGov Medicare Coverage of Innovative Technology pathway accelerates coverage for U.S. FDA breakthrough products. Medicare would provide 4 years of national coverage simultaneously with FDA approval.

On the latest episode of #FDAInsight, you'll learn about U.S. FDA's role in fighting the opioid crisis from Megan Moncur, Associate Director of Opioid Policy (FDA Drug Information). She shares timely advice for patients and consumers. Check it out here: go.usa.gov/xG4mW

Mitch Zeller, Director of FDA Tobacco, joins me in a #FDAInsight discussion on e-cigarettes (or vapes) and the 2020 National Youth Tobacco Survey results. Learn more about U.S. FDA's efforts to protect Americans from tobacco-related death and disease. go.usa.gov/xG5NS

LISTEN NOW: @DrMayneFDA from @FDAFood, joins #FDAInsight to discuss nutrition and chronic disease prevention. Subscribe on your favorite app… Apple: bit.ly/FDAInsight Google: bit.ly/FDAGoogle Pandora: bit.ly/FDAPandora Spotify: bit.ly/FDASpotify

Today on the #FDAInsight podcast, Dr. Steve Solomon (Director of FDA CVM (Center for Veterinary Medicine)) and I discuss antimicrobial resistance (#AMR) and U.S. FDA's One Health approach to combatting AMR. You can listen here: go.usa.gov/xGFNH

Viewpoint: US Food and Drug Administration Support for Oncology Drug Development During COVID-19 by Kushal T. Kadakia, Anand Shah, M.D. and Rick Pazdur ja.ma/3jMNIsn via JAMA Oncology

FDA's Anand Shah, M.D.: FDA looking at possible regulatory lessons to take away from the pandemic, including: - ⬆️Use of decentralized trials using digital health platforms and home delivery of meds - ⬆️Use of RWE to inform future studies and patient exp. jamanetwork.com/journals/jamao…

Dr. Kaveeta Vasisht of FDAWomen joins #FDAInsight to discuss the Office of Women's Health's work to advance the health of women through #FDA scientific programs, policy development, research, education and outreach. Check it out here: go.usa.gov/xGSCh

A big thank you to FDA Commissioner Dr. Stephen M. Hahn and Deputy Commissioners Dr. Amy Abernethy, Anand Shah, M.D., and Frank Yiannas for sharing their expertise and insights today at our Annual Public Meeting.

With the vaccines advisory committee meeting coming up this Thursday, now’s a great time to listen to this excellent podcast episode with a meeting primer from Dr. Peter Marks. #FDAInsight fda.gov/news-events/fd…

In this episode of #FDAInsight, Dr. Peter Marks discusses the flu vaccine, how it works, U.S. FDA's role in ensuring its safety, and the importance of getting vaccinated as soon as possible. Listen in here: go.usa.gov/x72Mk

Listen up! On today’s #FDAInsight, Anand Shah, M.D. welcomes CDER's Elizabeth Jungman to talk about hand sanitizers and #COVID19. Apple: bit.ly/FDAInsight Google: bit.ly/FDAGoogle Pandora: bit.ly/FDAPandora Spotify: bit.ly/FDASpotify

This week on #FDAInsight, Dr. Suzanne Schwartz joins Anand Shah, M.D. for a discussion on personal protective equipment and its critical role in helping to reduce the spread of #COVID19. bit.ly/FDAInsight

This week on #FDAInsight, Dr. Janet Maynard joins Anand Shah, M.D. for a discussion on our work advancing evaluation & development of products that demonstrate promise for the diagnosis & treatment of rare diseases. bit.ly/FDAInsight

This week on #FDAInsight, RADM Richardae Araojo joins Anand Shah, M.D. to discuss the FDA’s efforts to address minority health disparities among diverse racial and ethnic populations. fda.gov/news-events/fd…

On #FDAInsight, Dr. Jeffrey Baker, from our Office of Biotechnology Products at CDER, joins Anand Shah, M.D. for a discussion on FDA’s efforts in advanced manufacturing. bit.ly/FDAInsight

.U.S. FDA is committed to ensuring that cutting-edge digital health technologies are rapidly developed. We've issued many policies to spur innovation during the #COVID19 pandemic. Here we discuss the implications for future U.S. digital health innovation. rdcu.be/ccmND

In a new episode of the #FDAInsight podcast, Gail Bormel of FDA’s Center for Drug Evaluation and Research joins Anand Shah, M.D. for a discussion on drug compounding and its contribution to fighting #COVID19. fda.gov/news-events/fd…

In a new episode of the #FDAInsight podcast, Frank Yiannas joins Anand Shah, M.D. for a discussion on the New Era of Smarter Food Safety and how its blueprint impacts FDA’s #COVID19 response. bit.ly/FDAInsight

It was an honor and privilege to serve the American people. I’ll always be an advocate for FDA and public health. Signing off this account. Follow Anand Shah, MD for updates.